Clinical Trials Browser

Phase 3 × fosaprepitant × Plasma cell × Clear all

NCT07413809 2026-02-17

Prevention of Delayed CINV After Autologous Transplant: Olanzapine-Containing Regimen vs. Dexamethasone-Containing Regimen

Phase 3 Recruiting

Multiple Myeloma